By Business/Source
Currency:USD
2021/FY
Stock NameRevenueRatio
Development and commercialization of pharmaceutical applications of its patents and licensed rights196K100.00%
By Country/Region
Currency:USD
2021/FY
Stock NameRevenueRatio
Canada196K100.00%